Search
  1. Home
  2. Africa
  • News

Drug giant seeks to ensure local ARV availability

    JOHANNESBURG

    Swiss pharmaceutical company Roche is to help African firms produce generic versions of its second-line anti-AIDS drug, Saquinavir, as part of its Technology Transfer Initiative.

    William Burns, director of the Roche pharmaceutical division, said the transfer was vital to ensuring the local availability of antiretrovirals (ARV) and strengthening the capacity of local industries.

    "We have taken this step to help ensure the right medicines and formulations are available locally ... and hope to help as many manufacturers as possible in these hardest hit countries by sharing our knowledge," Burns said in a statement.

    Saquinavir, which is recommended by the World Health Organisation, is a protease inhibitor that prevents the HI virus from replicating itself when used in combination with other ARVs.

    This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

    Share this article

    Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

    We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

    Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

    Become a member of The New Humanitarian

    Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

    Join